查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
RNA 靶向小分子藥物發現市場與 COVID-19 影響分析，按適應症、按藥物、按給藥途徑、最終用戶、按國家和地區 - 2023 年的行業分析、市場規模、市場佔有率和預測 - 2030年
市場調查報告書
商品編碼
1339884

RNA 靶向小分子藥物發現市場與 COVID-19 影響分析，按適應症、按藥物、按給藥途徑、最終用戶、按國家和地區 - 2023 年的行業分析、市場規模、市場佔有率和預測 - 2030年

RNA Targeting Small Molecule Drug Discovery Market with COVID-19 Impact Analysis, By Indication, By Drug, By Route of Administration, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年 RNA 靶向小分子藥物發現市場規模為 12.081 億美元，2023 年至 2030 年年複合成長率為 21.8%。

RNA 靶向小分子藥物發現市場-市場動態：

  • 一些新技術和醫療保健行業提高了市場需求。
  • 為了擴展RNA分子的藥物能力，已經開發了各種新技術。因此，許多具有作用於當前和新型 RNA 靶點潛力的小分子也正在臨床前和臨床研究中進行研究，用於治療多種適應症，包括傳染病、遺傳性疾病和其他類型的癌症。因此，這些因素可能會推動對RNA靶向小分子藥物發現市場的需求。然而，藥物研究的高昂成本是市場成長的主要障礙之一。此外，預計RNA靶向小分子藥物發現行業可能會改變醫療保健部門目前治療各種疾病的方式。與此相一致的是，這些藥物通過選擇性靶向 RNA 分子發揮作用，RNA 分子對於藥物開發來說是有吸引力的目標，因為它們對於控制基因表達很重要。

RNA 靶向小分子藥物發現市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，全球 RNA 靶向小分子藥物發現市場預計在預測期內（2023-2030 年）每年將以 21.8% 左右的年複合成長率成長
  • 該市場率先開發了選擇性靶向 RNA 的藥物，為解決醫療需求未得到滿足的疾病（例如遺傳性疾病和某些癌症）提供了一種有前景的方法。
  • RNA 靶向小分子為藥物發現提供了新的維度，補充了傳統方法並擴大了可治療疾病的範圍，最終改善了患者的治療結果。
  • 按地區分類，北美是 2022 年的主要收入來源

RNA 靶向小分子藥物發現市場 - 細分分析：

  • 全球RNA靶向小分子藥物發現市場根據適應症、藥物、給藥途徑、最終用戶和地區進行細分。
  • 根據適應症將市場分為四類：神經系統疾病、癌症、代謝性疾病、傳染病等。癌症領域被認為主導市場。由於RNA靶向藥物僅針對癌細胞，並且專門針對與癌症相關的基因改變，因此與其他類型的癌症治療相比，RNA靶向藥物在功效和減少副作用方面具有前沿優勢。此外，對於癌症治療，各製藥公司正在大力投資 RNA 靶向藥物的發現，這可能會推動市場成長。
  • 根據藥物，市場分為六類：tomivosertib、translarna、risdiplam、ELX-02、ABX464 和 H3B-6545。 Translarna (TM) 業務預計將佔據最大的收入佔有率。它是為了治療由稱為無義突變的特定類型突變引起的遺傳性疾病而創建的。此外，這些突變可能導致多種遺傳性疾病，例如某些類型的囊性纖維化和肌營養不良症。此外，在 mRNA 中，Translarna (TM) 促進過早終止密碼子的“通讀”，使核醣體能夠繼續翻譯並產生全長的功能性蛋白質。這可能會減輕無義突變引起的遺傳性疾病的影響。
  • 根據給藥途徑，市場分為兩類：皮下注射和口服。口腔細分市場可能擁有最大的收入佔有率。由於其患者依從性和便利性，它是藥物輸送的重要首選途徑之一。開發小分子藥物口服給藥系統的優點是能夠通過口服途徑輕鬆給藥小分子藥物，避免侵入性操作，並可能提高患者對治療方案的依從性。
  • 市場根據最終用戶分為兩類：學術和研究機構、製藥和生物製藥公司等。製藥和生物製藥公司領域可能會在預測期內保持其主導地位。由於他們在藥物發現方面擁有豐富的經驗和資源，因此該領域預計將繼續主導市場。有各種中小型生物製藥行業進入市場。

RNA 靶向小分子藥物發現市場 - 地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

RNA靶向小分子藥物發現市場-競爭格局：

在競爭激烈的RNA靶向小分子藥物發現行業中，各個行業都在爭奪市場主導地位。這些行業憑藉其在 RNA 靶向藥物生產和開發方面的資源和經驗，在市場上佔有重要地位。此外，為了推出新療法並獲得監管許可，他們與監管組織和醫療保健提供者建立了聯繫。例如，2023年2月，ReviR Therapeutics與亞虹醫藥合作開發新的腫瘤療法。此外，此次合作的目標是開發泌尿生殖腫瘤和其他相關嚴重疾病的新療法。

最近的發展：

例如，2023 年 1 月，Atomic AI 發布了價值 3500 萬美元的系列產品，用於開發人工智慧驅動的 RNA 結構平台，用於治療不治之症。

該研究的主要特點：

  • 這項針對 RNA 靶向小分子藥物發現市場的研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030 年），以 2022 年為基準年。
  • 該報告為客戶提供了有關 RNA 靶向小分子藥物發現市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了針對小分子藥物發現市場的 RNA 有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、老牌參與者面臨的挑戰以及 RNA 靶向小分子藥物發現市場維持的成長因素。
  • COVID-19 對 RNA 靶向小分子藥物發現市場規模、預測、年複合成長率和市場動態的影響將在研究範圍下詳細討論。還將詳細介紹新冠疫情后 RNA 靶向小分子藥物發現市場。
  • 為了讓本報告的用戶全面了解RNA靶向小分子藥物發現市場，我們還對RNA靶向小分子藥物發現市場的競爭格局和關鍵創新者進行了分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這些參與者將幫助用戶了解在 RNA 靶向小分子藥物發現市場中營運的參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球RNA靶向小分子藥物發現市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和金融分析師。

目錄

第 1 章：RNA 靶向小分子藥物發現市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • RNA 靶向小分子藥物發現市場片段（按適應症）
    • RNA 靶向小分子藥物發現市場片段（按藥物）
    • RNA 靶向小分子藥物發現市場片段（按給藥途徑）
    • 最終用戶的 RNA 靶向小分子藥物發現市場片段
    • RNA 靶向小分子藥物發現市場片段（按國家/地區）
    • RNA 靶向小分子藥物發現市場片段（按地區）
  • 競爭洞察

第 3 章：RNA 靶向小分子藥物發現主要市場趨勢

  • RNA 靶向小分子藥物發現市場促進因素
    • 市場促進因素的影響分析
  • RNA 靶向小分子藥物發現市場限制
    • 市場限制影響分析
  • RNA 靶向小分子藥物發現市場機會
  • RNA靶向小分子藥物發現市場未來趨勢

第 4 章：RNA 靶向小分子藥物發現行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：RNA 靶向小分子藥物發現市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：RNA 靶向小分子藥物發現市場格局

  • 2022 年 RNA 靶向小分子藥物發現市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：RNA 靶向小分子藥物發現市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 神經系統疾病
    • 癌症
    • 代謝性疾病
    • 傳染病
    • 其他

第 8 章：RNA 靶向小分子藥物發現市場 - 按藥物

  • 概述
    • 按藥物分類的細分市場佔有率分析
    • 托米沃塞蒂布
    • 特蘭斯拉納 (TM)
    • 瑞斯迪普蘭
    • ELX-02
    • ABX464
    • H3B-6545

第 9 章：RNA 靶向小分子藥物發現市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 皮下
    • 口服

第 10 章：RNA 靶向小分子藥物發現市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 學術及研究機構
    • 製藥和生物製藥公司
    • 其他

第 11 章：RNA 靶向小分子藥物發現市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • RNA 靶向小分子藥物發現北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按藥物）
    • 北美市場規模和預測（按管理途徑）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • RNA 靶向小分子藥物發現歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按指標）
    • 歐洲市場規模和預測（按藥品）
    • 歐洲市場規模和預測（按管理途徑）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • RNA 靶向小分子藥物發現亞太地區主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按指標）
    • 亞太地區藥物市場規模和預測
    • 亞太地區市場規模和預測（按管理途徑）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • RNA 靶向小分子藥物發現拉丁美洲主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按指標）
    • 拉丁美洲市場規模和預測（按藥品）
    • 拉丁美洲市場規模和預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • RNA靶向小分子藥物發現中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按指標）
    • 中東和非洲市場規模及預測（按藥品）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - RNA 靶向小分子藥物發現行業

  • 競爭儀表板
  • 公司簡介
    • PTC Therapeutics
    • Accent Therapeutics
    • Expansion Therapeutics
    • Anima Biotech Inc.
    • Servier Laboratories
    • Arrakis Therapeutics
    • AstraZeneca
    • Skyhawk Therapeutics, Inc.
    • Epics Therapeutics
    • H3 Biomedicine Inc.
    • Hoffmann-La Roche Ltd
    • Ribometrix
    • AC immune
    • STORM Therapeutics

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1608

REPORT HIGHLIGHT

RNA targeting small molecule drug discovery Market size was valued at USD 1,208.1 Million in 2022, expanding at a CAGR of 21.8% from 2023 to 2030.

RNA targeting small molecules drug discovery refers to the process of examining and developing small molecule drugs that specifically inhibit and modulate the function of RNA molecules within cells. RNA, or ribonucleic acid, plays an essential role in several cellular processes, including regulation and gene expression. Moreover, a tiny molecule is an organic compound with a relatively low, molecular weight that can interact with biological targets including nucleic acids or proteins.

RNA Targeting Small Molecule Drug Discovery Market- Market Dynamics:

  • Several novel techniques and the healthcare sector raising the market demand.
  • To expand the drug ability of RNA molecules various novel techniques have been developed. As a result, numerous small molecules, with the potential of acting on current and novel RNA targets are also being studied in preclinical and clinical studies for the treatment of several indications, including infectious diseases, genetic diseases, and other types of cancers. Thus, such factors may drive the demand for the RNA targeting small molecules drug discovery market. However, the exorbitant cost of medication research is one of the main obstacles to the market growth. Moreover, it is projected that the RNA targeting small molecules drug discovery industry could transform the way the healthcare sector currently treats various diseases. In line with this, these drugs function by selectively targeting RNA molecules, which are appealing targets for drug development as they are important for controlling gene expression.

RNA Targeting Small Molecule Drug Discovery Market- Key Insights:

  • As per the analysis shared by our research analyst, the global RNA targeting small molecule drug discovery market is estimated to grow annually at a CAGR of around 21.8% over the forecast period (2023-2030)
  • This market pioneers the development of drugs that selectively target RNA, presenting a promising approach to tackle diseases with unmet medical needs, such as genetic disorders and certain cancers.
  • RNA-targeted small molecules offer new dimensions to drug discovery, complementing traditional approaches and broadening the scope of treatable conditions, ultimately improving patient outcomes.
  • On the basis of region, North America was the leading revenue generator in 2022

RNA Targeting Small Molecule Drug Discovery Market- Segmentation Analysis:

  • The global RNA targeting small molecule drug discovery market is segmented on the basis of indication, drug, route of administration, end-user, and region.
  • The market is divided into four categories based on indication: neurological diseases, cancer, metabolic diseases, infectious disease, and others. The cancer segment is accounted to dominate the market. As they target cancer cells only and are created to specifically target cancer-related genetic alterations, RNA-targeted drugs have a cutting-edge as compared to other types of cancer treatments in terms of efficacy and side effects reduction. Moreover, for cancer treatment various pharmaceutical companies are investing heavily in RNA-targeted drug discovery, which is likely to fuel the market growth.
  • The market is categorized into six categories based on the drug: tomivosertib, translarna, risdiplam, ELX-02, ABX464, and H3B-6545. The translarna™ segment is expected to witness the largest revenue share. It is created to treat genetic disorders caused by a particular type of mutation known as a nonsense mutation. Additionally, these mutations can lead to several genetic disorders such as certain types of cystic fibrosis and muscular dystrophy. Moreover, in the mRNA Translarna™ promotes "read-through" of the premature stop codon, allowing the ribosome to continue translating and create a full-length, functional protein. This might mitigate the effects of the genetic disorder caused by the nonsense mutation.
  • The market is segmented into two categories based on the route of administration: subcutaneous and oral. The oral segment is likely to possess the largest revenue share. As it is one of the crucial preferred routes for drug delivery owing to its patient compliance and convenience. The capability to administer small molecule medications easily by oral route, avoidance of invasive procedures, and potentially improved patient adherence to treatment regimens are the advantages of developing oral delivery systems for small molecule medications.
  • The market is divided into two categories based on end-user: academic and research institutes, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment is likely to maintain its dominance over the forecast period. As they have huge experience and resources in terms of drug discovery, and as a result, the segment is expected to continue to dominate the market. There are various small to medium-sized biopharmaceutical sectors penetrating the market.

RNA Targeting Small Molecule Drug Discovery Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

RNA Targeting Small Molecule Drug Discovery Market- Competitive Landscape:

In the competitive RNA-targeting small molecule drug discovery industry, various industries are contending for market dominance. These industries have a substantial presence on the market, based on their resources and experience in the production and development of RNA-targeted pharmaceuticals. Moreover, to introduce new treatments and get regulatory permission, they have developed connections with regulatory organizations and healthcare providers. For instance, in February 2023, ReviR Therapeutics collaborated with Asieris to develop new oncology therapies. Additionally, developing new treatments for genitourinary tumors and other related serious diseases is the aim of this collaboration.

Recent Developments:

For instance, in January 2023, Atomic AI released a $35 million series for the advancement of an AI-driven RNA structure platform for the treatment of incurable diseases.

Key features of the study:

  • This proposed research study on RNA targeting small molecule drug discovery market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the RNA targeting small molecule drug discovery market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for RNA targeting small molecule drug discovery market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the RNA targeting small molecule drug discovery market.
  • Impact of COVID-19 on RNA targeting small molecule drug discovery market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on RNA targeting small molecule drug discovery market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the RNA targeting small molecule drug discovery market, we have also included competitive landscape and key innovator analysis for the RNA targeting small molecule drug discovery market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the RNA targeting small molecule drug discovery market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global RNA targeting small molecule drug discovery market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET KEY PLAYERS

  • PTC Therapeutics
  • Accent Therapeutics
  • Expansion Therapeutics
  • Anima Biotech Inc.
  • Servier Laboratories
  • Arrakis Therapeutics
  • AstraZeneca
  • Skyhawk Therapeutics, Inc.
  • Epics Therapeutics
  • H3 Biomedicine Inc.
  • Hoffmann-La Roche Ltd
  • Ribometrix
  • AC immune
  • STORM Therapeutics

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY INDICATION

  • Neurological Diseases
  • Cancer
  • Metabolic Diseases
  • Infectious Disease
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY DRUG

  • Tomivosertib
  • Translarna
  • Risdiplam
  • ELX-02
  • ABX464
  • H3B-6545

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY ROUTE OF ADMINISTRATION

  • Subcutaneous
  • Oral
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY END-USER

  • Academic and Research Institutes
  • Pharmaceutical and Biopharmaceutical Companies
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RNA Targeting Small Molecule Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RNA Targeting Small Molecule Drug Discovery Market Snippet by Indication
    • 2.1.2. RNA Targeting Small Molecule Drug Discovery Market Snippet by Drug
    • 2.1.3. RNA Targeting Small Molecule Drug Discovery Market Snippet by Route of Administration
    • 2.1.4. RNA Targeting Small Molecule Drug Discovery Market Snippet by End-user
    • 2.1.5. RNA Targeting Small Molecule Drug Discovery Market Snippet by Country
    • 2.1.6. RNA Targeting Small Molecule Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. RNA Targeting Small Molecule Drug Discovery Key Market Trends

  • 3.1. RNA Targeting Small Molecule Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RNA Targeting Small Molecule Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RNA Targeting Small Molecule Drug Discovery Market Opportunities
  • 3.4. RNA Targeting Small Molecule Drug Discovery Market Future Trends

4. RNA Targeting Small Molecule Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RNA Targeting Small Molecule Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RNA Targeting Small Molecule Drug Discovery Market Landscape

  • 6.1. RNA Targeting Small Molecule Drug Discovery Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RNA Targeting Small Molecule Drug Discovery Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022&2030 (%)
    • 7.1.2. Neurological Diseases
    • 7.1.3. Cancer
    • 7.1.4. Metabolic Diseases
    • 7.1.5. Infectious Disease
    • 7.1.6. Others

8. RNA Targeting Small Molecule Drug Discovery Market - By Drug

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug, 2022&2030 (%)
    • 8.1.2. Tomivosertib
    • 8.1.3. Translarna™
    • 8.1.4. Risdiplam
    • 8.1.5. ELX-02
    • 8.1.6. ABX464
    • 8.1.7. H3B-6545

9. RNA Targeting Small Molecule Drug Discovery Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
    • 9.1.2. Subcutaneous
    • 9.1.3. Oral

10. RNA Targeting Small Molecule Drug Discovery Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2022&2030 (%)
    • 10.1.2. Academic and Research Institutes
    • 10.1.3. Pharmaceutical and Biopharmaceutical Companies
    • 10.1.4. Others

11. RNA Targeting Small Molecule Drug Discovery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- RNA Targeting Small Molecule Drug Discovery Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. PTC Therapeutics
    • 12.2.2. Accent Therapeutics
    • 12.2.3. Expansion Therapeutics
    • 12.2.4. Anima Biotech Inc.
    • 12.2.5. Servier Laboratories
    • 12.2.6. Arrakis Therapeutics
    • 12.2.7. AstraZeneca
    • 12.2.8. Skyhawk Therapeutics, Inc.
    • 12.2.9. Epics Therapeutics
    • 12.2.10. H3 Biomedicine Inc.
    • 12.2.11. Hoffmann-La Roche Ltd
    • 12.2.12. Ribometrix
    • 12.2.13. AC immune
    • 12.2.14. STORM Therapeutics

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Indication2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: DrugSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Drug2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: End-user Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-user
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by End-user 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Region 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)

List of Figures

  • FIGURE RNA Targeting Small Molecule Drug Discovery Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022&2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Drug segment market share analysis, 2022&2030
  • FIGURE Drug segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022&2030
  • FIGURE Route of Administrationsegment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-user segment market share analysis, 2022&2030
  • FIGURE End-user segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Germany RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE India RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Brazil RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)